West Pharmaceutical Services Inc.
04/26/2024 | Press release | Distributed by Public on 04/26/2024 14:18
Submission of Matters to a Vote of Security Holders - Form 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointments of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 26, 2024, West Pharmaceutical Services, Inc. ("West") announced an update to the role of Bernard Birkett, Chief Financial and Operations Officer. Since May 2022, Mr. Birkett served as both our Principal Financial and Principal Operating Officer. Mr. Birkett's leadership while in this combined role has greatly enhanced the operations capabilities of both our Proprietary Products and Contract Manufacturing Business Segments. This now allows us to transfer much of our operational leadership and decision-making to each of our Business Segments to further improve our efficiency. Effective May 1, 2024, Mr. Birkett's title will be solely Chief Financial Officer ("CFO"), where he will retain financial oversight for both Business Segments, operational oversight of our strategic sourcing function and be involved in key operational issues together with other members of our executive team. However, we will no longer have a single principal operating officer.